Dr. Stefanie G. Schuman
Overview
I am a Retinal Ophthalmologist and completed my fellowship at Duke. I joined the stellar Retina faculty here to provide exceptional care to patients. My approach with patients is to explain their retinal condition, and answer any questions they have. I am excited to be part of a team that provides the latest imaging technology to diagnose retinal disease, including macular diseases, vascular conditions, diabetic retinopathy, and medication related toxicities. I provide patients with all their options to treat their condition with the latest advancements.
Dr. Schuman is highly rated in 4 conditions, according to our data. Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinitis Pigmentosa, and X-Linked Retinitis Pigmentosa (XLRP).
Her clinical research consists of co-authoring 15 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2351 Erwin Rd, Durham, NC 27705
Additional Areas of Focus
Dr. Schuman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Eye Care Associates OD PA
Cynthia Toth is an Ophthalmologist in Durham, North Carolina. Dr. Toth is highly rated in 14 conditions, according to our data. Her top areas of expertise are Retinopathy of Prematurity, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Corneal Transplant.
Office
Alessandro Iannaccone is an Ophthalmologist in Chapel Hill, North Carolina. Dr. Iannaccone is highly rated in 29 conditions, according to our data. His top areas of expertise are Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, X-Linked Retinitis Pigmentosa (XLRP), and Usher Syndrome Type 2A.
Eye Care Associates OD PA
Scott Cousins is an Ophthalmologist in Durham, North Carolina. Dr. Cousins is highly rated in 15 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, and Diabetic Retinopathy.
Frequently Asked Questions about Dr. Stefanie G. Schuman
How do I make an appointment with Dr. Stefanie G. Schuman?
You can book an appointment with Dr. Stefanie G. Schuman by calling their office at 919-681-3937. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Stefanie G. Schuman a top-rated expert for Age-Related Macular Degeneration (ARMD)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Stefanie G. Schuman is classified as an Advanced expert for Age-Related Macular Degeneration (ARMD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Stefanie G. Schuman specialize in?
While Dr. Stefanie G. Schuman is a Ophthalmology, they have specific expertise in Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Retinitis Pigmentosa. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.
Does Dr. Stefanie G. Schuman participate in research or clinical trials?
Yes. Dr. Stefanie G. Schuman has published 15 articles and abstracts on conditions like Age-Related Macular Degeneration (ARMD). You can view a list of Dr. Stefanie G. Schuman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Stefanie G. Schuman accept my insurance?
Dr. Stefanie G. Schuman accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 919-681-3937 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Age-Related Macular Degeneration (ARMD)
- Late-Onset Retinal DegenerationDr. Schuman isAdvanced. Learn about Late-Onset Retinal Degeneration.
- Retinitis PigmentosaDr. Schuman isAdvanced. Learn about Retinitis Pigmentosa.
- X-Linked Retinitis Pigmentosa (XLRP)
- Experienced
- Central Serous ChorioretinopathyDr. Schuman isExperienced. Learn about Central Serous Chorioretinopathy.
- Cone DystrophyDr. Schuman isExperienced. Learn about Cone Dystrophy.
- Cone Rod Dystrophy Amelogenesis Imperfecta
- Cone-Rod DystrophyDr. Schuman isExperienced. Learn about Cone-Rod Dystrophy.
- Diabetic Macular Edema (DME)Dr. Schuman isExperienced. Learn about Diabetic Macular Edema (DME).
- Diabetic RetinopathyDr. Schuman isExperienced. Learn about Diabetic Retinopathy.